Company & Sponsor Intelligence

Boston Children's Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials15
Recruiting5
Completed8
Countries1

Therapeutic footprint

adhdautismepilepsyother_neurologysubstance_use

Indexed studies

NCT02461420Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
autism · United States
ACTIVE_NOT_RECRUITING
NCT01784276Dental Fear Among Children With Autism Spectrum Disorders
autism · United States
NA
NCT05650775Biomarkers of ADHD Treatment Response
adhd · United States
PHASE1
NCT02297347The Brain and Neuropsychological Functioning in Adults With Sapropterin Dihydrochloride Treated Phenylketonuria
other_neurology · United States
COMPLETED
NCT01511679Brain-imaging and Adolescent Neuroscience Consortium
substance_use · United States
WITHDRAWN
NCT07037030Mindfulness ADHD Intervention
adhd · United States
NA
NCT07458633Facilitating Autism Diagnosis in Shorter Timeframes by PCCs
autism ·
NA
NCT06221176Biomarkers Research in Anxiety for Validation and Efficacy
autism · United States
NA
NCT06701084Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis
epilepsy · United States
NA
NCT03363568Neuroplasticity Technology for Attention-deficit/Hyperactivity Disorder (ADHD)
adhd · United States
NA
NCT01160783Genetic Contributions to Autism Spectrum Disorders
autism · United States
ACTIVE_NOT_RECRUITING
NCT02836405TMS for the Investigation of Brain Plasticity in Autism Spectrum Disorders
autism · United States
COMPLETED

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →